Navigation Links
SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
Date:8/7/2008

ter the date hereof.

SGX PHARMACEUTICALS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

Three Months Ended Six Months Ended

June 30, June 30,

2008 2007 2008 2007

Revenue:

Collaborations and commercial

agreements $2,882 $5,722 $17,883 $11,369

Grants 1,424 2,784 3,395 8,105

Total revenue 4,306 8,506 21,278 19,474

Expenses:

Research and development 9,237 10,524 20,586 20,542

General and administrative 2,263 2,126 4,384 4,359

Total operating expenses 11,500 12,650 24,970 24,901

Loss from operations (7,194) (4,144) (3,692) (5,427)

Interest income (expense), net (7) 131 212 316

Net loss $(7,201) $(4,013) $(3,480) $(5,111)

Basic and diluted net loss

per share $(0.35) $(0.26) $(0.17) $(0.33)

Shares used to compute basic and

diluted net loss per share 20,650 15,337 20,590 15,281

Three Months Ended Three Months Ended

June 30, 2008 (1) June 30, 2007 (1)

Stock- Stock-

based Reported based Reported

compensation GAAP compensation GAAP

non-GAAP expense results non-GAAP expense results

Net loss $(6,339) $(862) $(7,201)
'/>"/>

SOURCE SGX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
2. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
3. Memory Pharmaceuticals to Announce Second Quarter 2008 Results on Wednesday, August 13, 2008
4. Watson Pharmaceuticals Reports Second Quarter 2008 Results
5. Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results
6. Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights
7. Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
8. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Two Investment Conferences During the Month of August 2008
9. Kowa Company, Ltd. Acquires ProEthic Pharmaceuticals, Inc.
10. Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals
11. Anacor Pharmaceuticals Appoints Dr. Kurt Jarnagin Vice President of Biological Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... Plant disease specialists from around the ... Annual Meeting of The American Phytopathological Society. Details ... now at APSnet.org/meet . , The Preliminary Daily ... be held August 1-5, 2015 in Pasadena, California, U.S.A. ... Workshops, and committee meetings, all carefully balanced to deliver ...
(Date:3/5/2015)... Triangle Park, NC (PRWEB) March 05, 2015 ... Inc., announced that Pierre Noel, M.D., Professor of ... elected to the Company’s Board of Directors. ... said, “We are extremely fortunate to have Dr. ... the country’s leading healthcare organization, join Entegrion’s Board. ...
(Date:3/5/2015)... and Markets ( http://www.researchandmarkets.com/research/4ld5nw/mature_biotech ) has announced ... New Therapy Ventures Pave the Way for Success" ... companies - Gilead (GILD), Amgen (AMGN), Biogen Idec (BIIB) ... positive return and hence increased the interest of biotech ... indication where the high treatment cost justifies the need. ...
(Date:3/5/2015)... 05, 2015 The next implants made ... the CE mark (European) approval. The CE mark is ... Association (EFTA) and the European Union. Following the Class ... granted to implants supplied by the Turkey-based company Osimplant ... , Osimplant's Cervical Expandable Bladed HA PEEK Cage line ...
Breaking Biology Technology:American Phytopathological Society Announces Annual Meeting Daily Schedule 2Entegrion Announces Appointment of Pierre Noel, MD, to Its Board of Directors 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 3Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 2Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 3
... includes upfront, milestone and royalty payments on future ... ... 8 /PRNewswire-FirstCall/ - Lorus Therapeutics Inc.,("Lorus") (TSX: LOR; AMEX: LRP), a ... technologies,for the management of cancer, announced today that its subsidiary GeneSense,Technologies, ...
... Dendreon Corporation,(Nasdaq: DNDN ) today announced ... offering of 8.0 million shares of its common,stock ... shares of its common,stock. Net proceeds received by ... served as sole placement agent for the offering., ...
... 2008 Diffusion,Pharmaceuticals LLC, a clinical-stage drug-development ... action that enhances,oxygen diffusion, today announced that ... entitled "Bipolar Trans Carotenoid Salts and Their ... of first-in-class new chemical entities,known as trans ...
Cached Biology Technology:Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R) 2Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R) 3Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R) 4Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R) 5Dendreon Announces Closing of Registered Direct Offering 2Diffusion Pharmaceuticals Announces Issuance of U.S. Patent No. 7351844, Titled 'Bipolar Trans Carotenoid Salts and Their Uses,' for Its Family of First-In-Class Molecules 2
(Date:2/18/2015)... -- Cepheid (NASDAQ: CPHD ) today announced that its ... investors to participate via webcast. , Cowen and Company ... March 3, 2015 at 11.20 a.m. Eastern Time , ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern Time ... for these events, please visit Cepheid,s website at http://ir.cepheid.com ...
(Date:2/12/2015)... Feb. 12, 2015   MedNet Solutions , ... clinical study management systems, has recently bolstered its ... distinguishing iMedNet as the ... (CROs) and healthcare consultants.  Building on the Program,s ... referrals and numerous co-marketing opportunities), MedNet,s new and ...
(Date:2/11/2015)... February 11, 2015 ... "Access Control Market by Product (Cards and Readers, Biometrics, ... Defense, Government, Industrial, Healthcare, Education) and By Geography - Global ... MarketsandMarkets, the Access Control Market is expected ... at a CAGR of 10.6% between 2014 ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4
... Grupo Radio Centro, S.A.B.,de C.V. ( RC, BMV: RCENTRO-A) (the "Company"), ... operations for,the quarter ended March 31, 2010 . All figures were prepared ... Research and Development of Financial Information Standards. , ... First Quarter Results , ...
... LOS ANGELES , April 26 , , , ... , WHO: Written by Evelina Fernandez . Directed ... , , WHERE: Los Angeles ... , , WHEN: Previews ...
... , Library Ribbon Cutting Ceremony to Commemorate JPMorgan Chase & Co. ... School District , , ... SAN JOSE, Calif. , April 26 Franklin McKinley School ... ceremony to celebrate the expansion of the San Jose Elementary School Library ...
Cached Biology News:Grupo Radio Centro Reports First Quarter 2010 Results 2Grupo Radio Centro Reports First Quarter 2010 Results 3Grupo Radio Centro Reports First Quarter 2010 Results 4Grupo Radio Centro Reports First Quarter 2010 Results 5Grupo Radio Centro Reports First Quarter 2010 Results 6Grupo Radio Centro Reports First Quarter 2010 Results 7Grupo Radio Centro Reports First Quarter 2010 Results 8Latino Theater Company Presents 'Dementia' Starting April 29 2JPMorgan Chase & Co., Invests $25,000 to Support Bring Me A Book's San Jose Elementary School Library Initiative 2JPMorgan Chase & Co., Invests $25,000 to Support Bring Me A Book's San Jose Elementary School Library Initiative 3
... A direct, simple approach ... the well surface of an ... anhydride maintains its integrity and ... under dry, room temperature conditions ...
AC input: 230 V...
... The lyophilization stabilizer is designed ... process and for long-term storage. ... toxic ingredients. It is a ... pH 7.2, and is superior to ...
... Freedom EVO Clinical is Tecans open platform ... enhance quality, safety and performance in the ... is provided by flexible barcode reading and ... mention that the system complies with the ...
Biology Products: